Universität zu Köln

Giesen, Nicola ORCID: 0000-0002-9615-2564, Sprute, Rosanne ORCID: 0000-0003-2457-6437, Ruthrich, Maria, Khodamoradi, Yascha, Mellinghoff, Sibylle C., Beutel, Gernot, Lueck, Catherina, Koldehoff, Michael, Hentrich, Marcus, Sandherr, Michael, von Bergwelt-Baildon, Michael, Wolf, Hans-Heinrich, Hirsch, Hans H., Wormann, Bernhard, Cornely, Oliver A., Koehler, Philipp ORCID: 0000-0002-7386-7495, Schalk, Enrico ORCID: 0000-0003-1892-5098 and Von Lilienfeld-Toal, Marie (2020). Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). Eur. J. Cancer, 140. S. 86 - 105. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Full text not available from this repository.

Abstract

Since its first detection in China in late 2019 the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the associated infectious disease COVID-19 continue to have a major impact on global healthcare and clinical practice. Cancer patients, in particular those with haematological malignancies, seem to be at an increased risk for a severe course of infection. Deliberations to avoid or defer potentially immunosuppressive therapies in these patients need to be balanced against the overarching goal of providing optimal antineoplastic treatment. This poses a unique challenge to treating physicians. This guideline provides evidence-based recommendations regarding prevention, diagnostics and treatment of SARS-CoV-2 infection and COVID-19 as well as strategies towards safe antineoplastic care during the COVID-19 pandemic. It was prepared by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO) by critically reviewing the currently available data on SARS-CoV-2 and COVID-19 in cancer patients applying evidence-based medicine criteria. (C) 2020 The Author(s). Published by Elsevier Ltd.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Giesen, Nicola UNSPECIFIED orcid.org/0000-0002-9615-2564 UNSPECIFIED Sprute, Rosanne UNSPECIFIED orcid.org/0000-0003-2457-6437 UNSPECIFIED Ruthrich, Maria UNSPECIFIED UNSPECIFIED UNSPECIFIED Khodamoradi, Yascha UNSPECIFIED UNSPECIFIED UNSPECIFIED Mellinghoff, Sibylle C. UNSPECIFIED UNSPECIFIED UNSPECIFIED Beutel, Gernot UNSPECIFIED UNSPECIFIED UNSPECIFIED Lueck, Catherina UNSPECIFIED UNSPECIFIED UNSPECIFIED Koldehoff, Michael UNSPECIFIED UNSPECIFIED UNSPECIFIED Hentrich, Marcus UNSPECIFIED UNSPECIFIED UNSPECIFIED Sandherr, Michael UNSPECIFIED UNSPECIFIED UNSPECIFIED von Bergwelt-Baildon, Michael UNSPECIFIED UNSPECIFIED UNSPECIFIED Wolf, Hans-Heinrich UNSPECIFIED UNSPECIFIED UNSPECIFIED Hirsch, Hans H. UNSPECIFIED UNSPECIFIED UNSPECIFIED Wormann, Bernhard UNSPECIFIED UNSPECIFIED UNSPECIFIED Cornely, Oliver A. UNSPECIFIED UNSPECIFIED UNSPECIFIED Koehler, Philipp UNSPECIFIED orcid.org/0000-0002-7386-7495 UNSPECIFIED Schalk, Enrico UNSPECIFIED orcid.org/0000-0003-1892-5098 UNSPECIFIED Von Lilienfeld-Toal, Marie UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-313397
DOI:	10.1016/j.ejca.2020.09.009
Journal or Publication Title:	Eur. J. Cancer
Volume:	140
Page Range:	S. 86 - 105
Date:	2020
Publisher:	ELSEVIER SCI LTD
Place of Publication:	OXFORD
ISSN:	1879-0852
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language CLINICAL CHARACTERISTICS; RISK-FACTORS; HAND-RUB; SARS-COV-2; MALIGNANCIES; MULTICENTER; MORTALITY; IMPACT; VIRUS; MASKS Multiple languages Oncology Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/31339